VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $572,000 | -24.7% | 39,932 | -9.1% | 0.01% | -37.5% |
| Q2 2017 | $760,000 | -64.2% | 43,912 | +110.0% | 0.02% | -90.2% |
| Q4 2015 | $2,125,000 | +333.7% | 20,907 | +661.1% | 0.16% | +110.3% |
| Q3 2015 | $490,000 | -82.4% | 2,747 | -78.1% | 0.08% | -29.7% |
| Q2 2015 | $2,790,000 | -46.1% | 12,555 | -51.8% | 0.11% | -46.4% |
| Q1 2015 | $5,176,000 | +112.6% | 26,063 | +53.2% | 0.21% | +64.3% |
| Q4 2014 | $2,435,000 | – | 17,015 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |